Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gianfranco Porcile"'
Autor:
Sergio, Bretti, Gianfranco, Porcile, Roberto, Romizi, Salvatore, Palazzo, Cristina, Oliani, Sergio, Crispino, Roberto, Labianca
Publikováno v:
Tumori Journal. 100:e94-e97
For decades Western medicine has followed a biomedical model based on linear thinking and an individualized, disease-oriented doctor-patient relationship. Today this framework must be replaced by a biopsychosocial model based on complexity theory and
Autor:
Nidia Sofia Diaz Gaitan, Francesco Grossi, Francesco Boccardo, Carlo Genova, Stefan Walzer, Giulia Barletta, Paolo Pronzato, Erika Rijavec, Claudio Sini, Caterina Donato, Maria Giovanna Dal Bello, Sabrina Beltramini, Gianfranco Porcile
Publikováno v:
Lung Cancer. 81:236-240
Background The cost of new anti-cancer drugs has dramatically increased in recent years, and countermeasures are required in order to limit pharmaceutical expenses. Sponsored clinical trials that provide drugs free of charge may be a useful tool in o
Autor:
Federico Castiglione, Cristina Granetto, Milena Gasco, Gabriella Mariani, Pietro La Ciura, Gianfranco Porcile, Gianmauro Numico, Marco Merlano, Oliviero Ostellino, Ornella Garrone, Gianna Di Costanzo
Publikováno v:
Lung Cancer. 35:59-64
Polyethylene glycol-coated (pegylated) liposomal doxorubicin (PLD) is a new formulation of doxorubicin with peculiar pharmacokinetic and pharmacodinamic properties, a favorable toxic profile and a demonstrated activity in solid tumors. We tested PLD
Autor:
Gianfranco, Porcile
Publikováno v:
Epidemiologia e prevenzione. 38(2)
Autor:
Gianfranco Porcile
Publikováno v:
Pratica Medica & Aspetti Legali; Vol 5, No 2 (2011); 51-52
[Sentinel doctors: the 007 of the environment]
Autor:
Danila Comandini, C. Naso, C Simoni, V. Fusco, Lazzarono Repetto, L. Merlini, Antonella Venturino, Riccardo Rosso, Gianfranco Porcile, Paolo Pronzato, Raffaella Palumbo
Publikováno v:
Breast cancer research and treatment. 60(3)
Metastatic breast cancer remains an incurable disease and the median overall survival has not significantly improved over the past two decades. Aims of the present randomized phase II trial were to analyse activity and toxicity of chemotherapies with
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 29(1)
Amifostine protects healthy tissues but not tumor cells from the damage induced by cytotoxic treatments, particularly ionizing radiations, alkylating and platinating agents. The clinical effectiveness of amifostine has been demonstrated by randomized
Autor:
Paola Antonelli, Editta Baldini, Luca Boni, A. Altieri, Silvio Monfardini, Adolfo Favaretto, Gianfranco Porcile, Andrea Ardizzoni, Franca Pari, Adriano Paccagnella
Publikováno v:
Lung Cancer. 41:S233
Publikováno v:
Lung Cancer. 29:65
Autor:
A Ziade, Riccardo Rosso, Andrea Ardizzoni, Mario Spatafora, Adriano Paccagnella, M. Raimondi, Enrico Aitini, Gianfranco Porcile, L. Tixi, Adolfo Favaretto, Luca Boni, Salvati F, M Donghi, Antonio Antilli, Santi Barbera, G Cacciani
Publikováno v:
Lung Cancer. 29:9